Last $5.24 USD
Change Today +0.04 / 0.77%
Volume 22.6K
SYUT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Berlin
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

synutra international inc (SYUT) Snapshot

Open
$5.20
Previous Close
$5.20
Day High
$5.31
Day Low
$5.09
52 Week High
01/22/14 - $9.48
52 Week Low
10/1/14 - $4.27
Market Cap
300.3M
Average Volume 10 Days
40.5K
EPS TTM
$0.67
Shares Outstanding
57.3M
EX-Date
--
P/E TM
7.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for SYNUTRA INTERNATIONAL INC (SYUT)

synutra international inc (SYUT) Related Bloomberg News

View More Bloomberg News

synutra international inc (SYUT) Related Businessweek News

No Related Businessweek News Found

synutra international inc (SYUT) Details

Synutra International, Inc., through its subsidiaries, produces, markets, and distributes dairy based nutritional products primarily under the Shengyuan or Synutra name in the People’s Republic of China. The company operates in four segments: Powdered Formula, Foods, Nutritional Ingredients and Supplements, and Other Business. The Powdered Formula segment sells powdered infant and adult formula products under the Super, U-Smart, My Angel, and Dutch Cow brand names. The Foods segment sells prepared baby foods for babies, children, and adults under the Huiliduo brand name; and prepared adult foods for patients with special nutritional needs after surgical operations. The Nutritional Ingredients and Supplements segment produces and sells nutritional ingredients and supplements, such as chondroitin sulfate, microencapsulated docosahexanoic acid, and arachidonic acid. The Other Business segment sells milk powder, raw milk, and whey protein products to industrial customers. The company sells its products through sales and distribution network covering various provinces and provincial-level municipalities in Mainland China. Synutra International, Inc. is headquartered in Rockville, Maryland.

3,200 Employees
Last Reported Date: 06/16/14

synutra international inc (SYUT) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $381.3K
President and Chief Operating Officer
Total Annual Compensation: $112.8K
Chief Financial Officer
Total Annual Compensation: $107.3K
Vice President of Human Resources & Administr...
Total Annual Compensation: $190.9K
Vice President of Production and Director
Total Annual Compensation: $135.5K
Compensation as of Fiscal Year 2014.

synutra international inc (SYUT) Key Developments

Synutra International Inc. Announces Resignation of David Li as Director

Synutra International Inc. announced that effective November 11, 2014, David Li, a Managing Director with Warburg Pincus Asia LLC, has resigned from the company’s board of directors to focus on his other business commitments. Mr. Li's decision to resign did not involve any disagreement with the company.

Synutra International Inc. Presents at Goldman Sachs Greater China CEO Summit 2014, Nov-17-2014

Synutra International Inc. Presents at Goldman Sachs Greater China CEO Summit 2014, Nov-17-2014 . Venue: JW Marriott Hotel, Hong Kong.

Synutra International Inc. Announces Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2014; Revises Earnings Guidance for the Fiscal Year 2015

Synutra International Inc. announced consolidated earnings results for the second quarter and six months ended September 30, 2014. For the quarter, the company reported net sales of $102,464,000 against $88,556,000 a year ago. Income from operations was $13,638,000 against $8,902,000 a year ago. Income before income tax expense was $11,549,000 against $6,012,000 a year ago. Net income attributable to common stockholders was $10,237,000 against $6,073,000 a year ago. Basic and diluted earnings per share were $0.18 against $0.11 a year ago. For the six months, the company reported net sales of $188,439,000 against $170,761,000 a year ago. Income from operations was $37,941,000 against $15,816,000 a year ago. Income before income tax expense was $32,772,000 against $10,867,000 a year ago. Net income attributable to common stockholders was $28,177,000 against $10,848,000 a year ago. Basic and diluted earnings per share were $0.49 against $0.19 a year ago. For the fiscal first half of fiscal 2015, cash generated from operating activities was $9.5 million, a decrease from $32.6 million in the prior year period due to the increases in current assets. Cash outflow for capital expenditure in the first six months were $44.3 million, which mainly represented expenditures for the drying facility project in France. The company continues to expect strong top line growth and greater operating leverage in fiscal 2015, with full year infant formula segment sales expected to grow by at least 20% over fiscal 2014 results. This growth is expected to be primarily driven by increased sales volume while ASP remains largely unchanged. Assuming the same sales ratio as fiscal 2014 for all product segments, total revenue growth is also expected to be at least 20% over last year, or between $450 and $500 million. The company has raised its net income guidance for fiscal 2015 from $50 million to $60 million to $55 million to $65 million. This represents bottom line growth of at least 75% over fiscal 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SYUT:US $5.24 USD +0.04

SYUT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $45.85 USD +0.15
Biostime International Holdings Ltd $15.40 HKD +0.10
Danone SA €54.32 EUR -0.20
Inner Mongolia Yili Industrial Group Co Ltd CNY27.55 CNY +0.54
Mead Johnson Nutrition Co $102.49 USD +0.45
View Industry Companies
 

Industry Analysis

SYUT

Industry Average

Valuation SYUT Industry Range
Price/Earnings 6.2x
Price/Sales 0.8x
Price/Book 3.8x
Price/Cash Flow 6.2x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNUTRA INTERNATIONAL INC, please visit www.synutra.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.